USCareCheck

CMS certification 263302

The Children's Mercy Hospital

2401 Gillham Road, Kansas City, MO 64108

Childrens Emergency services

This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.

CMS overall rating Not rated Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.
Would definitely recommend No survey results published
Patient survey rating Not rated HCAHPS patient survey
Compared with the nation Too few cases for CMS to compare

What patients said

Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.

Data are shown only for hospitals that participate in the Inpatient Quality Reporting (IQR) and Outpatient Quality Reporting (OQR) programs.

Not reported for this hospital

CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.

Clinicians registered at this address

2,033 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 81 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.

Specialty Clinicians
Pediatrics 526
Family 117
Neonatal 79
Pediatric Emergency Medicine 67
Clinical Child & Adolescent 60
Neonatal-Perinatal Medicine 53
Pediatric Cardiology 51
Clinical 48
Dietitian, Registered 47
Nurse Practitioner 46
Pediatric Hematology-Oncology 45
Physical Therapist 42

First 12 alphabetically

Money from drug and device companies

Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.

2025 total $4.1M general $225,192 · research $3.9M
All years, 2019–2025 $21.3M 4,613 reported payments
Studies funded, 2025 84 58 companies paid in total
  • 2019 $3M
  • 2020 $2.3M
  • 2021 $3.2M
  • 2022 $3M
  • 2023 $3M
  • 2024 $2.7M
  • 2025 $4.1M

General payments Research payments

What the 2025 general payments were for

Type of payment Amount Payments
Speaking, teaching and other services $102,195 6
Consulting fees $90,000 3
Medical devices and supplies on long-term loan $23,522 8
Space rental and facility fees $4,550 6
Grants $4,000 1
Education $700 1
Charitable contributions $225 2

Largest paying companies, 2025

Company Amount Payments
Ultragenyx Pharmaceutical Inc. $802,049 77
Sanofi Pasteur INC. $649,600 21
Jazz Pharmaceuticals INC. $417,419 4
Vertex Pharmaceuticals Incorporated $330,738 5
Rhythm Pharmaceuticals, Inc. $235,447 213
Edwards Lifesciences Corporation $184,142 50
Gen-Probe, Inc. $176,457 5
Alexion Pharmaceuticals, Inc. $161,228 4

Largest research studies funded here, 2025

Study Amount
GTX-102-CL301 Ultragenyx Pharmaceutical Inc. · NCT06617429 $583,065
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome (SOS) JAZZ PHARMACEUTICALS INC. $405,419
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway Rhythm Pharmaceuticals, Inc. $235,422
Comparison of nasal swab and nasopharyngeal swab for respiratory testing using Hologic Panther Fusion assay Gen-Probe, Inc. $176,457
UX143-CL301 Ultragenyx Pharmaceutical Inc. $152,412
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults … SANOFI PASTEUR INC. · NCT06686654 $125,000
COMPASSION S3 2015-01 Edwards Lifesciences Corporation $120,913
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic… VERTEX PHARMACEUTICALS INCORPORATED $117,390

Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.

How to read this page

  • Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
  • “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
  • Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
  • Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
  • These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.

CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error

Common questions about The Children's Mercy Hospital

Does The Children's Mercy Hospital have an emergency room?

Yes. CMS lists emergency services at The Children's Mercy Hospital.

Does The Children's Mercy Hospital receive money from drug and device companies?

Drug and device makers reported $4.1M in payments to The Children's Mercy Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.